Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Review of Hematology|April 7, 2020
Risk assessment of venous thromboembolism in hematological cancer patients: a reviewThomas Sau-Yan Chan, Yu Yan Hwang, Eric Tse
Discovery Medicine|August 6, 2013
Novel therapeutic agents for T-cell lymphomasThomas Sau-Yan Chan, Yok-Lam Kwong, Eric Tse
Journal of Hematology & Oncology|May 9, 2015
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9David Chau, Karen Ng, Thomas Sau-Yan Chan, et al.
Virology Journal|August 1, 2023
Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapyLok-Ka Lam, Thomas Sau Yan Chan, Yu-Yan Hwang, et al.
Annals of Palliative Medicine|July 9, 2021
Early integrated palliative care for haematology cancer patients-the impact on symptom burden in Hong KongKwok Ying Chan, Harinder Gill, Thomas Sau Yan Chan, et al.
Journal of Medical Economics|November 6, 2020
Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong KongThomas Sau-Yan Chan, Sally Shuk-Yee Cheng, Wei-Ting Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2018
Monitoring and Treatment of Patients Undergoing Immunotherapy With Anti-CD20 Who are Exposed to HBVWai-Kay Seto, Thomas Sau-Yan Chan, Yu-Yan Hwang, et al.
The American Journal of Gastroenterology|September 21, 2016
Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive TherapyWai-Kay Seto, Danny Ka-Ho Wong, Thomas Sau-Yan Chan, et al.
Journal for Immunotherapy of Cancer|March 28, 2025
Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myelomaChunxiang Jin, Rongrong Chen, Shan Fu, et al.
Pageof 2